Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Advisory Council on Financing and Access to Sickle Cell Disease Treatment and Other High-Cost Drugs and Treatment

TITLE

Advisory Council on Financing and Access to Sickle Cell Disease Treatment and Other High-Cost Drugs and Treatment (Advisory Council)

Meeting Notice

FUNCTION

 The Advisory Council on Financing and Access to Sickle Cell Disease Treatment and Other High-Cost Drugs and Treatment ("Advisory Council") is established for the purpose of advising HFS in the development of payment models and financing structures for sickle cell disease treatment and other high-cost drugs and treatment that support equitable access and contribute to national efforts to formulate solutions.

 

 

TERMS

 

 Determined by Executive order of the Governor of Illinois

 

COMPENSATION

 The two members with lived experience may be provided an honorarium to reimburse them for their time, not to exceed $250 per meeting.

 

 

CHAIRPERSONS

 

 Director of HFS will serve as the Chair.

 

 

AUTHORITY

 

 Executive Order 2024-01 (illinois.gov)

 

 

HFS WEB SITE

 

 Boards and Commissions | HFS (illinois.gov)

 

State of IL GOv APPOINTMENTS WEB SITE

Boards and Commissions Details - Appointments (illinois.gov)